Researchers will investigate the safety and efficacy of using donated stem cells to treat dogs with naturally occurring osteoarthritis that have limited treatment options.

Researchers will investigate the role of a signaling pathway in the progression of bone cancer in dogs and evaluate its potential as a new therapeutic target to help treat this disease.

Researchers will determine whether the fur of animal-assistance therapy dogs can become contaminated with hospital-associated infections and test whether low-costinterventions can reduce the risk of microbial transmission between therapy animals and patients with childhood cancer.

Researchers will test specialized filters that may reduce life-threatening transfusion reactions in dogs.

Researchers will investigate the efficacy of a new pain relief option, the transdermal lidocaine patch, for dogs that undergo surgery.

Researchers will use genetic fingerprinting methods to track and help prevent serious antibiotic-resistant staph infection outbreaks in dogs and cats.

Researchers will identify new therapy targets for malignant mast cell tumors, acommon and aggressive cancer in dogs.

Researchers will evaluate a novel drug as a potential new treatment for immunemediated hemolytic anemia, a serious and fatal blood disorder in dogs.

Researchers will investigate how metabolic processes affect tumor growth andchemotherapy resistance in dogs with hemangiosarcoma and ways to block or disrupt these processes.

Researchers will determine what causes abnormal mucus secretion in dogs resulting in gallbladder mucoceles (congealed masses of mucus that can block or rupture the gallbladder), as well as seek ways to prevent or reverse this serious condition.